Back to 
Jacobs Levy Equity Management, Inc.
Jacobs Levy Equity Management, Inc.
QNCX
Showing 0 of 2 quarters
Position history for Jacobs Levy Equity Management, Inc.'s holdings in QUINCE THERAPEUTICS INC
No. Jacobs Levy Equity Management exited its QNCX (Quince Therapeutics) position in Q4 2022. Its Q3 2022 13F listed 489,073 shares worth $650,000. Jacobs Levy Equity Management first reported QNCX in Q3 2022 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.